Intrinsiqq
Opko Health Inc. logo

Opko Health Inc. Insider Trading

OPK

⊜ Compare
Last 12 months

Insiders bought 11K on the open market and sold nothing.

Net open-market
+11K
1 buy · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
1 / 0
executives and directors
Last open-market buy
Mar 2026
Mar 20, 2026

Get an email when OPK's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Mar 20
    John A Paganelli
    Director · bought 10,000 at $1.14
    11K
    2.5% of stake
  • Nov 21, 2025
    Frost Gamma Investments Trust
    Large holder · bought 580,000 at avg $1.33
    770K
    0.2% of stake
  • Nov 20, 2025
    Frost Gamma Investments Trust
    Large holder · bought 580,000 at avg $1.33
    772K
    0.2% of stake
  • Nov 19, 2025
    Frost Gamma Investments Trust
    Large holder · bought 580,000 at avg $1.31
    761K
    0.2% of stake
  • Nov 18, 2025
    Frost Gamma Investments Trust
    Large holder · bought 533,300 at avg $1.28
    681K
    0.2% of stake
  • Oct 31, 2025
    Phillip Md Et Al Frost
    CEO & Chairman · bought 150,000 at $1.42
    213K
    <0.1% of stake
  • Aug 8, 2025
    Phillip Md Et Al Frost
    CEO & Chairman · bought 675,000 at $1.32
    891K
    0.3% of stake
  • Apr 10, 2025
    Phillip Md Et Al Frost
    CEO & Chairman · bought 125,000 at $1.36
    170K
    <0.1% of stake
  • Apr 8, 2025
    Frost Gamma Investments Trust
    Large holder · bought 125,000 at $1.48
    185K
    <0.1% of stake
  • Apr 1, 2025
    Phillip Md Et Al Frost
    CEO & Chairman · bought 100,000 at $1.65
    165K
    <0.1% of stake
  • Mar 28, 2025
    Frost Gamma Investments Trust
    Large holder · bought 150,000 at $1.70
    255K
    <0.1% of stake
  • Mar 17, 2025
    Frost Gamma Investments Trust
    Large holder · bought 200,000 at $1.74
    348K
    <0.1% of stake
  • Feb 28, 2025
    Frost Gamma Investments Trust
    Large holder · bought 67,434 at $1.71
    115K
    <0.1% of stake
  • Jan 28, 2025
    Frost Gamma Investments Trust
    Large holder · bought 47,537 at $1.47
    70K
    <0.1% of stake
  • Jan 17, 2025
    Frost Gamma Investments Trust
    Large holder · bought 150,000 at $1.47
    221K
    <0.1% of stake
  • Jan 15, 2025
    Phillip Md Et Al Frost
    CEO & Chairman · bought 500,000 at $1.48
    740K
    0.2% of stake
  • Dec 13, 2024
    Frost Gamma Investments Trust
    Large holder · bought 125,000 at $1.60
    200K
    <0.1% of stake
  • Dec 11, 2024
    Frost Gamma Investments Trust
    Large holder · bought 500,000 at $1.56
    780K
    0.2% of stake
  • Nov 29, 2024
    Frost Gamma Investments Trust
    Large holder · bought 199,072 at $1.53
    305K
    <0.1% of stake
  • Nov 22, 2024
    Frost Gamma Investments Trust
    Large holder · bought 100,000 at $1.59
    159K
    <0.1% of stake
  • Nov 14, 2024
    Phillip Md Et Al Frost
    CEO & Chairman · bought 100,000 at $1.62
    162K
    <0.1% of stake
  • Nov 8, 2024
    Frost Gamma Investments Trust
    Large holder · bought 280,183 at $1.50
    420K
    0.1% of stake
  • Nov 8, 2024
    Phillip Md Et Al Frost
    CEO & Chairman · bought 280,183 at $1.50
    420K
    0.1% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch OPK, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with OPK

CompareIntrinsic value
TVTXTravere Therapeutics Inc.
$52.64+6.54%52
CPRXCatalyst Pharmaceuticals Inc.
No recent price73
MIRMMirum Pharmaceuticals Inc.
$95.00+9.16%30
HCMHUTCHMED (China) Ltd
$13.92+6.42%45
FOLDAmicus Therapeutics, Inc.
No recent price45
VREOFVireo Growth Inc.
$7.29-2.15%30
ARWRArrowhead Pharmaceuticals Inc.
$61.65+3.56%40
RAREUltragenyx Pharmaceutical Inc.
$17.16+3.19%40

Held by ETFs

OPK is in 15 US ETFs. The largest of them, with OPK's weight in each:

Spot a number that looks wrong? Check it in OPK's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing OPK

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.